| Product Code: ETC7657559 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oligodendroglioma Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oligodendroglioma Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Oligodendroglioma Market - Industry Life Cycle |
3.4 Israel Oligodendroglioma Market - Porter's Five Forces |
3.5 Israel Oligodendroglioma Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.6 Israel Oligodendroglioma Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Israel Oligodendroglioma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Oligodendroglioma Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Israel Oligodendroglioma Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.10 Israel Oligodendroglioma Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Israel Oligodendroglioma Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
4 Israel Oligodendroglioma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of oligodendroglioma cases in Israel |
4.2.2 Technological advancements in diagnostic tools and treatment options for oligodendroglioma |
4.2.3 Growing investments in healthcare infrastructure and research in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for new treatment approvals in Israel |
4.3.2 High treatment costs associated with oligodendroglioma therapies |
4.3.3 Limited awareness and understanding of oligodendroglioma among patients and healthcare professionals in Israel |
5 Israel Oligodendroglioma Market Trends |
6 Israel Oligodendroglioma Market, By Types |
6.1 Israel Oligodendroglioma Market, By Grade |
6.1.1 Overview and Analysis |
6.1.2 Israel Oligodendroglioma Market Revenues & Volume, By Grade, 2021- 2031F |
6.1.3 Israel Oligodendroglioma Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.1.4 Israel Oligodendroglioma Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.2 Israel Oligodendroglioma Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Oligodendroglioma Market Revenues & Volume, By Bevacizumab, 2021- 2031F |
6.2.3 Israel Oligodendroglioma Market Revenues & Volume, By Alisertib, 2021- 2031F |
6.2.4 Israel Oligodendroglioma Market Revenues & Volume, By Dasatinib, 2021- 2031F |
6.2.5 Israel Oligodendroglioma Market Revenues & Volume, By DCVax-L, 2021- 2031F |
6.2.6 Israel Oligodendroglioma Market Revenues & Volume, By CDX-1401, 2021- 2031F |
6.2.7 Israel Oligodendroglioma Market Revenues & Volume, By IMA-950, 2021- 2031F |
6.3 Israel Oligodendroglioma Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Oligodendroglioma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.3 Israel Oligodendroglioma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.4 Israel Oligodendroglioma Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.3.5 Israel Oligodendroglioma Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.3.6 Israel Oligodendroglioma Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Oligodendroglioma Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 Israel Oligodendroglioma Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.4.3 Israel Oligodendroglioma Market Revenues & Volume, By CT scan, 2021- 2031F |
6.4.4 Israel Oligodendroglioma Market Revenues & Volume, By MRI, 2021- 2031F |
6.4.5 Israel Oligodendroglioma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.4.6 Israel Oligodendroglioma Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Oligodendroglioma Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Israel Oligodendroglioma Market Revenues & Volume, By Tablet, 2021- 2031F |
6.5.3 Israel Oligodendroglioma Market Revenues & Volume, By Injection, 2021- 2031F |
6.5.4 Israel Oligodendroglioma Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Oligodendroglioma Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Israel Oligodendroglioma Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Israel Oligodendroglioma Market Revenues & Volume, By Intravenou, 2021- 2031F |
6.6.4 Israel Oligodendroglioma Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Israel Oligodendroglioma Market, By Symptoms |
6.7.1 Overview and Analysis |
6.7.2 Israel Oligodendroglioma Market Revenues & Volume, By Headaches, 2021- 2031F |
6.7.3 Israel Oligodendroglioma Market Revenues & Volume, By Weakness, 2021- 2031F |
6.7.4 Israel Oligodendroglioma Market Revenues & Volume, By Numbness, 2021- 2031F |
6.7.5 Israel Oligodendroglioma Market Revenues & Volume, By Numbness, 2021- 2031F |
6.7.6 Israel Oligodendroglioma Market Revenues & Volume, By Seizures, 2021- 2031F |
6.7.7 Israel Oligodendroglioma Market Revenues & Volume, By Problems with balance and movement, 2021- 2031F |
6.8 Israel Oligodendroglioma Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 Israel Oligodendroglioma Market Revenues & Volume, By Clinic, 2021- 2031F |
6.8.3 Israel Oligodendroglioma Market Revenues & Volume, By Hospital, 2021- 2031F |
6.8.4 Israel Oligodendroglioma Market Revenues & Volume, By , 2021- 2031F |
7 Israel Oligodendroglioma Market Import-Export Trade Statistics |
7.1 Israel Oligodendroglioma Market Export to Major Countries |
7.2 Israel Oligodendroglioma Market Imports from Major Countries |
8 Israel Oligodendroglioma Market Key Performance Indicators |
8.1 Average time to diagnosis for oligodendroglioma patients in Israel |
8.2 Adoption rate of advanced imaging techniques for oligodendroglioma diagnosis |
8.3 Number of clinical trials and research studies focused on oligodendroglioma in Israel |
8.4 Patient survival rates post-treatment for oligodendroglioma in Israel |
8.5 Percentage of healthcare providers offering specialized care for oligodendroglioma in Israel |
9 Israel Oligodendroglioma Market - Opportunity Assessment |
9.1 Israel Oligodendroglioma Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.2 Israel Oligodendroglioma Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Israel Oligodendroglioma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Oligodendroglioma Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 Israel Oligodendroglioma Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.6 Israel Oligodendroglioma Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Israel Oligodendroglioma Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.7 Israel Oligodendroglioma Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Oligodendroglioma Market - Competitive Landscape |
10.1 Israel Oligodendroglioma Market Revenue Share, By Companies, 2024 |
10.2 Israel Oligodendroglioma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here